Literature DB >> 29497178

In cervical spondylotic myelopathy spinal cord motion is focally increased at the level of stenosis: a controlled cross-sectional study.

Katharina Wolf1,2, Markus Hupp3, Susanne Friedl3, Reto Sutter4, Markus Klarhöfer5, Patrick Grabher3, Patrick Freund3,6,7,8, Armin Curt3.   

Abstract

STUDY
DESIGN: Level-, age-, and gender-matched controlled cross-sectional cohort study.
OBJECTIVES: To investigate alterations of spinal cord (SC) motion within cervical spondylotic myelopathy (CSM) across the cervical spinal segments and its relation to cerebrospinal fluid (CSF)-flow, anatomic conditions, and clinical parameters.
SETTING: University Hospital Balgrist, Zurich, Switzerland.
METHODS: Overall, 12 patients suffering from CSM at level C5 and 12 controls underwent cardiac-gated 2D phase-contrast-MRI at level C2 and C5 and standard MRI sequences. Parameters of interest: Velocity measurements of SC and CSF (area under the curve = total displacement (normalization for duration of the heart cycle), total displacement ratio (C5/C2; intraindividual normalization for confounders)), spinal canal diameters, clinical motor- and sensory scores, and performance measures.
RESULTS: Interrater reliability was excellent for SC motion at both levels and for CSF flow at C2, but not reliable for CSF flow at C5. Within controls, SC motion at C2 positively correlated with SC motion at C5 (p = 0.000); this correlation diminished in patients (p = 0.860). SC total displacement ratio was significantly increased in patients (p = 0.029) and correlated with clinical impairment (p = 0.017). Morphometric measures of the extent of stenosis were not related to SC motion or clinical symptoms.
CONCLUSION: The findings revealed physiological interactions of CSF flow and SC motion across the cervical spine in healthy controls while being diminished in CSM patients. Findings of focally increased SC motion at the level of stenosis were related to clinical impairment and might be promising as a diagnostic and prognostic marker in CSM. SPONSORSHIP: CRPP Neurorehab of the University of Zurich, Switzerland.

Entities:  

Mesh:

Year:  2018        PMID: 29497178     DOI: 10.1038/s41393-018-0075-1

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  30 in total

1.  The origin and significance of spinal cord pulsation.

Authors:  H Matsuzaki; K Wakabayashi; K Ishihara; H Ishikawa; H Kawabata; T Onomura
Journal:  Spinal Cord       Date:  1996-07       Impact factor: 2.772

Review 2.  Current and emerging MR imaging techniques for the diagnosis and management of CSF flow disorders: a review of phase-contrast and time-spatial labeling inversion pulse.

Authors:  S Yamada; K Tsuchiya; W G Bradley; M Law; M L Winkler; M T Borzage; M Miyazaki; E J Kelly; J G McComb
Journal:  AJNR Am J Neuroradiol       Date:  2014-07-10       Impact factor: 3.825

3.  Increased flow signal in compressed segments of the spinal cord in patients with cervical spondylotic myelopathy.

Authors:  Han Soo Chang; Takahide Nejo; Shinsuke Yoshida; Soichi Oya; Toru Matsui
Journal:  Spine (Phila Pa 1976)       Date:  2014-12-15       Impact factor: 3.468

4.  Cerebrospinal fluid flow in adults.

Authors:  William G Bradley; Victor Haughton; Kent-Andre Mardal
Journal:  Handb Clin Neurol       Date:  2016

5.  Pulsatile cerebrospinal fluid flow measurement using phase-contrast magnetic resonance imaging in patients with cervical myelopathy.

Authors:  Ryoichi Shibuya; Kazuo Yonenobu; Toshiaki Koizumi; Yasuji Kato; Motoharu Mitta; Hideki Yoshikawa
Journal:  Spine (Phila Pa 1976)       Date:  2002-05-15       Impact factor: 3.468

6.  Identification of the Upward Movement of Human CSF In Vivo and its Relation to the Brain Venous System.

Authors:  Steffi Dreha-Kulaczewski; Arun A Joseph; Klaus-Dietmar Merboldt; Hans-Christoph Ludwig; Jutta Gärtner; Jens Frahm
Journal:  J Neurosci       Date:  2017-01-30       Impact factor: 6.167

7.  Intramedullary high signal intensity and neurological status as prognostic factors in cervical spondylotic myelopathy.

Authors:  Jun Jae Shin; Byung Ho Jin; Keun Su Kim; Yong Eun Cho; Woo Ho Cho
Journal:  Acta Neurochir (Wien)       Date:  2010-05-29       Impact factor: 2.216

Review 8.  Cervical spondylotic myelopathy: the clinical phenomenon and the current pathobiology of an increasingly prevalent and devastating disorder.

Authors:  Sukhvinder Kalsi-Ryan; Spyridon K Karadimas; Michael G Fehlings
Journal:  Neuroscientist       Date:  2012-11-30       Impact factor: 7.519

Review 9.  Cerebrospinal Fluid Dynamics and the Pathophysiology of Hydrocephalus: New Concepts.

Authors:  Shinya Yamada; Erin Kelly
Journal:  Semin Ultrasound CT MR       Date:  2016-01-07       Impact factor: 1.875

10.  Human brain motion and cerebrospinal fluid circulation demonstrated with MR velocity imaging.

Authors:  D A Feinberg; A S Mark
Journal:  Radiology       Date:  1987-06       Impact factor: 11.105

View more
  8 in total

Review 1.  Degenerative cervical myelopathy - update and future directions.

Authors:  Jetan H Badhiwala; Christopher S Ahuja; Muhammad A Akbar; Christopher D Witiw; Farshad Nassiri; Julio C Furlan; Armin Curt; Jefferson R Wilson; Michael G Fehlings
Journal:  Nat Rev Neurol       Date:  2020-01-23       Impact factor: 42.937

2.  The Restless Spinal Cord in Degenerative Cervical Myelopathy.

Authors:  M Hupp; N Pfender; K Vallotton; J Rosner; S Friedl; C M Zipser; R Sutter; M Klarhöfer; J M Spirig; M Betz; M Schubert; P Freund; M Farshad; A Curt
Journal:  AJNR Am J Neuroradiol       Date:  2021-02-04       Impact factor: 3.825

3.  Segmental differences of cervical spinal cord motion: advancing from confounders to a diagnostic tool.

Authors:  M Hupp; K Vallotton; C Brockmann; S Huwyler; J Rosner; R Sutter; M Klarhoefer; P Freund; M Farshad; A Curt
Journal:  Sci Rep       Date:  2019-05-15       Impact factor: 4.379

4.  Assessment of spinal cord motion as a new diagnostic MRI-parameter in cervical spinal canal stenosis: study protocol on a prospective longitudinal trial.

Authors:  Katharina Wolf; Axel J Krafft; Karl Egger; Jan-Helge Klingler; Ulrich Hubbe; Marco Reisert; Marc Hohenhaus
Journal:  J Orthop Surg Res       Date:  2019-10-12       Impact factor: 2.359

5.  The Dancing Cord: Inherent Spinal Cord Motion and Its Effect on Cord Dose in Spine Stereotactic Body Radiation Therapy.

Authors:  Murat Alp Oztek; Nina A Mayr; Mahmud Mossa-Basha; Matthew Nyflot; Patricia A Sponseller; Wei Wu; Christoph P Hofstetter; Rajiv Saigal; Stephen R Bowen; Daniel S Hippe; William T C Yuh; Robert D Stewart; Simon S Lo
Journal:  Neurosurgery       Date:  2020-11-16       Impact factor: 4.654

6.  A New Framework for Investigating the Biological Basis of Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 5]: Mechanical Stress, Vulnerability and Time.

Authors:  Benjamin M Davies; Oliver Mowforth; Aref-Ali Gharooni; Lindsay Tetreault; Aria Nouri; Rana S Dhillon; Josef Bednarik; Allan R Martin; Adam Young; Hitoshi Takahashi; Timothy F Boerger; Virginia Fj Newcombe; Carl Moritz Zipser; Patrick Freund; Paul Aarne Koljonen; Ricardo Rodrigues-Pinto; Vafa Rahimi-Movaghar; Jefferson R Wilson; Shekar N Kurpad; Michael G Fehlings; Brian K Kwon; James S Harrop; James D Guest; Armin Curt; Mark R N Kotter
Journal:  Global Spine J       Date:  2022-02

7.  Proposing a Framework to Understand the Role of Imaging in Degenerative Cervical Myelopathy: Enhancement of MRI Protocols Needed for Accurate Diagnosis and Evaluation.

Authors:  Carl M Zipser; Michael G Fehlings; Konstantinos Margetis; Armin Curt; Michael Betz; Iwan Sadler; Lindsay Tetreault; Benjamin M Davies
Journal:  Spine (Phila Pa 1976)       Date:  2022-06-29       Impact factor: 3.241

8.  Study protocol for an observational study of cerebrospinal fluid pressure in patients with degenerative cervical myelopathy undergoing surgical deCOMPression of the spinal CORD: the COMP-CORD study.

Authors:  Carl Moritz Zipser; Nikolai Pfender; Jose Miguel Spirig; Michael Betz; Jose Aguirre; Markus Hupp; Mazda Farshad; Armin Curt; Martin Schubert
Journal:  BMJ Open       Date:  2020-09-21       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.